Sotorasib, AMG 510 2296729-00-3
ISO COA 2 Inquiries
2296729-00-3
Pharmaceutical Grade
99%
Shanghai
Zentrachem
25kgs in drum
Yes
2025-11-30
pharmaceutical intermediates,excipients,plant extracts,food additives,CDMO,fine cheimcals
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSotorasib (AMG510) is a chiral compound and a potent KRAS G12C covalent inhibitor with potential antitumor activity.
ChEBI:Sotorasib is a pyridopyrimidine that is pyrido[2,3-d]pyrimidin-2(1H)-one substituted by 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro and 2-fluoro-6-hydroxyphenyl groups at positions 1, 4, 6 and 7, respectively. It is approved for the treatment of patients with non-small cell lung cancer having KRAS(G12C) mutations. It has a role as an antineoplastic agent. It is a member of acrylamides, a N-acylpiperazine, a pyridopyrimidine, a member of monofluorobenzenes, a member of methylpyridines, a tertiary carboxamide, a tertiary amino compound and a member of phenols.
Sotorasib, also known as AMG-510, is an acrylamide derived KRAS inhibitor developed by Amgen. It is indicated in the treatment of adult patients with KRAS G12C mutant non small cell lung cancer. This mutation makes up >50% of all KRAS mutations. Mutant KRAS discovered in 1982 but was not considered a druggable target until the mid-2010s. It is the first experimental KRAS inhibitor. The drug [MRTX849] is also currently being developed and has the same target. Sotorasib was granted FDA approval on 28 May 2021.
Class: non-kinase; Treatment: KRAS(G12C) NSCLC; Other name: AMG 510; Elimination half-life: 5.5 h; Protein binding = 89%CertificatesBasic Info-
Product Name:
Sotorasib
Other Name:PYRIDO[2,3-D]PYRIMIDIN-2(1H)-ONE, 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-1-[4-METHYL-2-(1-METHYLETHYL;Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)-;AMG-510(Sotorasib);6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one;Storasib;CID 137278711;Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)- 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one;Sotorasib
CAS No.:2296729-00-3
Molecular Formula:C30H30F2N6O3
InChIKeys:NXQKSXLFSAEQCZ-UHFFFAOYSA-N
Molecular Weight:560.6
Color/Form:White to yellow
Categories:
Characteristics-
Density:
1.36±0.1 g/cm3(Predicted)
Boiling Point:730.5±70.0 °C(Predicted)
Water Solubility:Water : 33.33 mg/mL (59.46 mM; ultrasonic and adjust pH to 11 with NaOH)
PKA:6.52±0.35(Predicted)
Critical Temperature & Pressure:Store at -20°C, stored under nitrogen
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
pharmaceutical intermediates,excipients,plant extracts,food additives,CDMO,fine cheimcals
-
Location:
Rm 301, Bld 2, Taohuahu Neighborhood Center, Hangzhou, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,100% TT in advance
-
Average lead Time:
14 days
-
Total Employees:
5-10
-
Year of Establishment:
2025
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
Pakistan
Sotorasib
1 MT Sep 9, 2026
Pakistan
Sotorasib
1 KG Sep 24, 2026 Post an enquiry for this product
More from this Seller
-
-
-
N,N'-Disuccinimidyl Carbonate(DSC) 74124-79-1
Pharmaceutical Grade / 99%
-
-
-
-
N-Methyldiethanolamine 105-59-9 high purity
Pharmaceutical Grade / 99%
-
-
-
-
4-BroMo-2,3-dihydro-1H-indene 6134-53-8
Pharmaceutical Grade / 99%
-
-
-
-
DMI 1,3-Dimethyl-2-imidazolidinone 99% CAS 80-73-9
Pharmaceutical Grade / 99%
-
-
-
-
2,2'-Dithiobis(benzothiazole) 120-78-5
Pharmaceutical Grade / 99%
-
-
-
-
(1R,2R)-(-)-Trans-1-Amino-2-Indanol 163061-73-2
Pharmaceutical Grade / 99%
-